Unum Group (NYSE:UNM – Get Free Report) updated its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 9.120-9.450 for the period, compared to the consensus EPS estimate of 9.100. The company issued revenue guidance of -.
Unum Group Stock Performance
Shares of UNM traded down $0.32 during trading hours on Tuesday, hitting $75.91. The stock had a trading volume of 1,257,534 shares, compared to its average volume of 1,053,594. The firm has a market capitalization of $13.86 billion, a price-to-earnings ratio of 8.21, a PEG ratio of 1.08 and a beta of 0.80. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a 50-day moving average price of $74.23 and a 200 day moving average price of $64.84. Unum Group has a fifty-two week low of $46.64 and a fifty-two week high of $77.69.
Unum Group (NYSE:UNM – Get Free Report) last posted its earnings results on Tuesday, February 4th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.14 by ($0.11). Unum Group had a return on equity of 15.21% and a net margin of 13.76%. As a group, research analysts anticipate that Unum Group will post 8.54 EPS for the current year.
Unum Group Announces Dividend
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the stock. Barclays upped their price objective on shares of Unum Group from $76.00 to $85.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. BMO Capital Markets initiated coverage on shares of Unum Group in a research note on Thursday, January 23rd. They issued an “outperform” rating and a $91.00 price target on the stock. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $79.00 price objective (up from $74.00) on shares of Unum Group in a research note on Tuesday, January 7th. Morgan Stanley lifted their price target on Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 30th. Finally, Wells Fargo & Company increased their price objective on Unum Group from $74.00 to $81.00 and gave the company an “overweight” rating in a research note on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, Unum Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.00.
Check Out Our Latest Report on Unum Group
Insider Buying and Selling at Unum Group
In other Unum Group news, CAO Walter Lynn Rice, Jr. sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $69.56, for a total value of $104,340.00. Following the sale, the chief accounting officer now owns 8,361 shares of the company’s stock, valued at $581,591.16. The trade was a 15.21 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total value of $769,200.00. Following the completion of the sale, the executive vice president now owns 54,827 shares in the company, valued at $4,217,292.84. This represents a 15.43 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 102,914 shares of company stock worth $7,677,945 in the last ninety days. 0.93% of the stock is owned by insiders.
About Unum Group
Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.
Read More
- Five stocks we like better than Unum Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What is a Stock Market Index and How Do You Use Them?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Unum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unum Group and related companies with MarketBeat.com's FREE daily email newsletter.